Title of article
A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient
Author/Authors
Anoun, S 20 Aout Hospital - Hematology pediatric oncology department, Morocco , Lamchahab, M 20 Aout Hospital - Hematology pediatric oncology department, Morocco , Qachouh, M 20 Aout Hospital - Hematology pediatric oncology department, Morocco , Benchekroun, S 20 Aout Hospital - Hematology pediatric oncology department, Morocco , Quessar, A 20 Aout Hospital - Hematology pediatric oncology department, Morocco
From page
25
To page
28
Abstract
Methotrexate is an anti-rheumatic agent used as a first-line treatment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Methotrexate, but are very uncommon. We report here the first Moroccan case of RA patient on low dose MTX, who developed AML. We also reviewed all similar cases.
Journal title
Iranian Journal of Blood and Cancer (IJBC)
Journal title
Iranian Journal of Blood and Cancer (IJBC)
Record number
2669168
Link To Document